Hollow porous particles in metered dose inhalers

被引:143
作者
Dellamary, LA
Tarara, TE
Smith, DJ
Woelk, CH
Adractas, A
Costello, ML
Gill, H
Weers, JG
机构
[1] Alliance Pharmaceut Corp, San Diego, CA 92121 USA
[2] Electron Microscopy Serv, San Diego, CA 92109 USA
关键词
asthma; pulmonary drug delivery; metered dose inhaler; particle engineering; spray-drying; suspensions; HFA-134a;
D O I
10.1023/A:1007513213292
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To assess the physical stability and aerosol characteristics of suspensions of hollow porous microspheres (PulmoSpheres(TM)) in HFA-134a. Methods. Cromolyn sodium, albuterol sulfate, and formoterol fumarate microspheres were prepared by a spray-drying method. Particle size and morphology were determined via electron microscopy. Particle aggregation and suspension creaming times were assessed visually, and aerosol performance was determined via Andersen cascade impaction and dose uniformity studies. Results. The hollow porous particle morphology allows the propellant to permeate freely within the particles creating a novel form of suspension termed a homodispersion(TM), wherein the dispersed and continuous phases ate identical, separated by an insoluble interfacial layer of drug and excipient. Homodispersion formation improves suspension stability by minimizing the difference in density between the particles and the medium, and by reducing attractive forces between particles. The improved physical stability leads to excellent dose uniformity. Excellent aerosolization efficiencies are also observed with PulmoSpheres formulations, with fine particle fractions of about 70%. Conclusions. The formation of hollow porous particles provides a new formulation technology for stabilizing suspensions of drugs in hydrofluoroalkane propellants with improved physical stability, content uniformity, and aerosolization efficiency.
引用
收藏
页码:168 / 174
页数:7
相关论文
共 11 条
[1]   EFFECT OF AEROSOL-PARTICLE SIZE ON BRONCHODILATATION WITH NEBULIZED TERBUTALINE IN ASTHMATIC SUBJECTS [J].
CLAY, MM ;
PAVIA, D ;
CLARKE, SW .
THORAX, 1986, 41 (05) :364-368
[2]   Large porous particles for pulmonary drug delivery [J].
Edwards, DA ;
Hanes, J ;
Caponetti, G ;
Hrkach, J ;
BenJebria, A ;
Eskew, ML ;
Mintzes, J ;
Deaver, D ;
Lotan, N ;
Langer, R .
SCIENCE, 1997, 276 (5320) :1868-1871
[3]  
ELVECROG J, 1997, PHARM TECHNOL EUR, V9, P52
[4]   DELIVERY OF ALBUTEROL AND IPRATROPIUM BROMIDE FROM 2 NEBULIZER SYSTEMS IN CHRONIC STABLE ASTHMA - EFFICACY AND PULMONARY DEPOSITION [J].
JOHNSON, MA ;
NEWMAN, SP ;
BLOOM, R ;
TALAEE, N ;
CLARKE, SW .
CHEST, 1989, 96 (01) :6-10
[5]   APPROACHES AND CHALLENGES TO USE FREON PROPELLANT REPLACEMENTS [J].
LEACH, CL .
AEROSOL SCIENCE AND TECHNOLOGY, 1995, 22 (04) :328-334
[6]   STRATOSPHERIC SINK FOR CHLOROFLUOROMETHANES - CHLORINE ATOMIC-CATALYSED DESTRUCTION OF OZONE [J].
MOLINA, MJ ;
ROWLAND, FS .
NATURE, 1974, 249 (5460) :810-812
[7]  
PUREWAL TS, 1998, METERED DOSE INHALER
[8]   THE PREFERENTIAL DEPOSITION OF INHALED ISOPROTERENOL AND PROPRANOLOL IN ASTHMATIC-PATIENTS [J].
RUFFIN, RE ;
DOLOVICH, MB ;
OLDENBURG, FA ;
NEWHOUSE, MT .
CHEST, 1981, 80 (06) :904-907
[9]  
SMITH B, 1995, PHYS WORLD, V8, P9
[10]  
THIEL CG, 1996, RESP DRUG DELIVERY, V5, P115